AVIXIN ALPHA INJ

AVIXIN ALPHA INJ (아빅신알파 주) s an immune-modulating injection that contains thymosin alpha-1, a naturally occurring peptide involved in T-cell development and immune response regulation. It is used to strengthen immunity, particularly in patients with weakened immune systems due to chronic illness, cancer, or viral infections.

Composition

• Thymosin-α1: 1.6 mg
• Excipients: D-mannitol, phosphate buffers, water for injection

Benefits

• Enhances T-cell and natural killer (NK) cell function
• Improves immune response to vaccines (e.g., flu vaccines in elderly)
• Adjuvant in cancer immunotherapy (e.g., liver, lung, melanoma)
• Helpful in chronic viral infections (like hepatitis B, C, and HIV)
• May support recovery in respiratory viral infections

How to Use

• Route: Subcutaneous (SC) or Intramuscular (IM) injection
• Dose: Typically 1.6 mg (1 vial) twice per week
• Duration: Usually 4 weeks (can be extended depending on condition)

Side Effects & Precautions

• Usually well-tolerated
• Mild redness or irritation at the injection site
• Possible: fever, fatigue, joint pain, temporary ALT elevation
• Caution in patients with autoimmune diseases or on immunosuppressants